STAT3 and melanoma: As shown in Figure 4A–4D, IT treatment (20, 40 and 80 μM) for 24 h decreased the phosphorylated STAT3 at the tyrosine705 (tyr705) site in a dose-dependent manner in human melanoma A375S, A375R, A2058 and MEWO cells.